[go: up one dir, main page]

FR3115365B1 - Analyseur d’urine pour contrôler l’observance thérapeutique - Google Patents

Analyseur d’urine pour contrôler l’observance thérapeutique Download PDF

Info

Publication number
FR3115365B1
FR3115365B1 FR2010806A FR2010806A FR3115365B1 FR 3115365 B1 FR3115365 B1 FR 3115365B1 FR 2010806 A FR2010806 A FR 2010806A FR 2010806 A FR2010806 A FR 2010806A FR 3115365 B1 FR3115365 B1 FR 3115365B1
Authority
FR
France
Prior art keywords
urine
user
compliance
monitoring
therapeutic compliance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR2010806A
Other languages
English (en)
Other versions
FR3115365A1 (fr
Inventor
Sounderya Nagarajan
Christelle Barakat
David Campo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Withings SAS
Original Assignee
Withings SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Withings SAS filed Critical Withings SAS
Priority to FR2010806A priority Critical patent/FR3115365B1/fr
Priority to US18/249,491 priority patent/US20230380759A1/en
Priority to EP21807189.2A priority patent/EP4232815A1/fr
Priority to PCT/FR2021/051826 priority patent/WO2022084622A1/fr
Publication of FR3115365A1 publication Critical patent/FR3115365A1/fr
Application granted granted Critical
Publication of FR3115365B1 publication Critical patent/FR3115365B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/525—Multi-layer analytical elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
    • A61B10/0045—Devices for taking samples of body liquids
    • A61B10/007—Devices for taking samples of body liquids for taking urine samples
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/20—Measuring for diagnostic purposes; Identification of persons for measuring urological functions restricted to the evaluation of the urinary system
    • A61B5/207—Sensing devices adapted to collect urine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4833—Assessment of subject's compliance to treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6887—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient mounted on external non-worn devices, e.g. non-medical devices
    • A61B5/6891—Furniture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient; User input means
    • A61B5/742—Details of notification to user or communication with user or patient; User input means using visual displays
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/493—Physical analysis of biological material of liquid biological material urine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/528—Atypical element structures, e.g. gloves, rods, tampons, toilet paper
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2600/00—Assays involving molecular imprinted polymers/polymers created around a molecular template
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/70—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving creatine or creatinine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Analyseur d’urine pour contrôler l’observance thérapeutique L’invention concerne un dispositif d’analyse d’urine (1) pour contrôler l’observance d’un utilisateur à un traitement comprenant la prise régulière d’un médicament, le dispositif comportant un canal de collecte (4) pour collecter l’urine de l’utilisateur lorsque celui-ci effectue une miction dans des toilettes, et un module d’analyse (3) configuré pour détecter la présence d’un analyte dans l’urine collectée par le canal de collecte, l’analyte étant un principe actif du médicament ou un métabolite du principe actif, le module d’analyse étant configuré pour déterminer une concentration en analyte dans l’urine collectée ou une grandeur liée par une fonction monotone à la concentration en analyte dans l’urine. Elle concerne aussi un système et un procédé de contrôle de l’observance thérapeutique d’un utilisateur. Figure pour l’abrégé : Fig. 1
FR2010806A 2020-10-21 2020-10-21 Analyseur d’urine pour contrôler l’observance thérapeutique Active FR3115365B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR2010806A FR3115365B1 (fr) 2020-10-21 2020-10-21 Analyseur d’urine pour contrôler l’observance thérapeutique
US18/249,491 US20230380759A1 (en) 2020-10-21 2021-10-20 Urine analyzer to monitor compliance
EP21807189.2A EP4232815A1 (fr) 2020-10-21 2021-10-20 Analyseur d'urine pour contrôler l'observance thérapeutique
PCT/FR2021/051826 WO2022084622A1 (fr) 2020-10-21 2021-10-20 Analyseur d'urine pour contrôler l'observance thérapeutique

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2010806A FR3115365B1 (fr) 2020-10-21 2020-10-21 Analyseur d’urine pour contrôler l’observance thérapeutique
FR2010806 2020-10-21

Publications (2)

Publication Number Publication Date
FR3115365A1 FR3115365A1 (fr) 2022-04-22
FR3115365B1 true FR3115365B1 (fr) 2025-02-14

Family

ID=74871465

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2010806A Active FR3115365B1 (fr) 2020-10-21 2020-10-21 Analyseur d’urine pour contrôler l’observance thérapeutique

Country Status (4)

Country Link
US (1) US20230380759A1 (fr)
EP (1) EP4232815A1 (fr)
FR (1) FR3115365B1 (fr)
WO (1) WO2022084622A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115372351A (zh) * 2022-09-15 2022-11-22 北京大学第一医院 一种口服抗凝药的抗凝评估系统及存储介质
EP4388998A1 (fr) * 2022-12-19 2024-06-26 Withings Bande de test pour cartouche de dispositif d'analyse optique d'urine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160041146A1 (en) * 2014-08-11 2016-02-11 Ameritox, Ltd. Methods of normalizing the ratio of measured parent and metabolite drug concentrations in fluids and testing for non-compliance
CN111093494A (zh) * 2017-06-23 2020-05-01 沃扬特诊断公司 医疗诊断系统和方法
US10921310B2 (en) * 2017-07-27 2021-02-16 Asghar D. Mostafa Bio-fluid analysis and reporting system and method

Also Published As

Publication number Publication date
EP4232815A1 (fr) 2023-08-30
FR3115365A1 (fr) 2022-04-22
US20230380759A1 (en) 2023-11-30
WO2022084622A1 (fr) 2022-04-28

Similar Documents

Publication Publication Date Title
Nes et al. Self-regulatory deficits in fibromyalgia and temporomandibular disorders
FR3115365B1 (fr) Analyseur d’urine pour contrôler l’observance thérapeutique
EP2695573A3 (fr) Système d'analyse de composant de fluide et procédé pour contrôler et réguler le glucose
US20160015321A1 (en) Oral health monitoring and management
US20050110950A1 (en) Saccadic motion sensing
FR2747027A1 (fr) Procede de determination de la profondeur d'anesthesie et dispositif pour la mise en oeuvre de ce procede
US20220074918A1 (en) Toilet Tracking Timing of Excreta Events
Peng et al. Influencing factors for saliva urea and its application in chronic kidney disease
Zanotto et al. Frailty and falls in people living with multiple sclerosis
Shearer et al. Comparison of glucose point-of-care values with laboratory values in critically ill patients
Monaghan et al. Measurement properties of backward walking and its sensitivity and feasibility in predicting falls in people with multiple sclerosis
Chan et al. Daily-life walking speed, running duration and bedtime from wrist-worn sensors predict incident dementia: a Watch Walk–UK Biobank study
JP3911519B2 (ja) 腸内ガス中の有毒ガスの測定方法及び装置
CN110546504B (zh) 信息提供方法、信息处理系统、信息终端及信息处理方法
CN109620250A (zh) 一种震颤检测提示帕金森患病风险手环及其使用方法
US10258261B2 (en) System for analyzing customized test strips
US20180140284A1 (en) Medical Toilet with User Customized Health Metric Validation System
JP6952280B2 (ja) 情報提供方法、情報処理システム、情報端末、及び情報処理方法
JP6887098B2 (ja) 情報提供方法、情報処理システム、情報端末、及び情報処理方法
CN109480812A (zh) 一种基于物联网通讯的脉搏健康数据管理系统
US20210241874A1 (en) Overdose diagnostic and treatment device and method
CN111751492A (zh) 呼出气体检测方法和装置
Moore et al. Dental Anxiety among Danish Adults—Comparison of Recent Website Data and Older Telephone Data with Government Demographic Statistics
Wagner et al. Requirements for an evaluation infrastructure for reliable pervasive healthcare research
CN119073918B (zh) 一种基于同步采集的脑电-胃电信号的癫痫预测系统

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20220422

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6